Lead sponsor

Moscow Regional Research and Clinical Institute (MONIKI)

1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

1

Trials led

0

Active

130

Total enrollment

1

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Not applicable
1

Trials by status

Completed
1

Trials led

Adiponectin in Patients With Metabolic DisordersBMI 25-39.9not applicableCompleted130